搜索临床试验以:埃克替尼治疗 2 年
总计2770个结果
-
The First Affiliated Hospital of Soochow UniversityFundamenta Therapeutics, Ltd.招聘中
-
University of CopenhagenAarhus University Hospital; Medical Research Council; Region Capital Denmark; Mental Health Centre...完全的
-
University of Massachusetts, WorcesterAgency for Healthcare Research and Quality (AHRQ); Omnicare Clinical Research; Qualidigm完全的
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)主动,不招人
-
KLS MartinClinical Study Centers, LLC招聘中
-
Fox Chase Cancer CenterNovartis终止
-
University Hospital, Bordeaux招聘中
-
Shanghai Municipal Center for Disease Control and...Shanghai Institute Of Biological Products未知
-
Zhejiang Chinese Medical UniversityRed Cross Hospital, Hangzhou, China; The Third Affiliated hospital of Zhejiang Chinese Medical... 和其他合作者完全的
-
London School of Hygiene and Tropical MedicineRadboud University Medical Center; Groupe de Recherche Action en Sante招聘中
-
Czech Lymphoma Study GroupHoffmann-La Roche; Ministry of Health, Czech Republic完全的
-
Betta Pharmaceuticals Co., Ltd.未知
-
University of RochesterNational Institute on Drug Abuse (NIDA)完全的
-
Second Affiliated Hospital, School of Medicine,...Tongji Hospital; Qilu Hospital of Shandong University; First Hospital of China Medical University 和其他合作者招聘中
-
Helsinki University Central Hospital主动,不招人对直径为 11-20mm 的低风险甲状腺乳头状癌患者安全地省略放射性碘治疗
-
Novartis Pharmaceuticals主动,不招人慢性粒细胞白血病比利时, 西班牙, 奥地利, 德国, 意大利, 法国, 荷兰, 瑞典, 日本, 美国, 希腊, 英国, 保加利亚, 匈牙利, 阿根廷, 波兰, 哥伦比亚, 爱尔兰, 丹麦
-
Odense University HospitalNovo Nordisk A/S; Department of Nephrology, Odense University Hospital; The A.P. Moller Foundation 和其他合作者招聘中
-
University of Roma La Sapienza未知
-
University of LiverpoolImperial College London; Newcastle University; University of Glasgow未知
-
University Hospital, LilleMinistry of Health, France; Laboratoire français de Fractionnement et de Biotechnologies终止
-
AstraZenecaAcerta Pharma, LLC完全的